Florian Markowetz secures European Research Council Advanced Grant
The European Research Council today announced the winners of its 2021 Advanced Grants competition. The funding, worth in total €624.6 million, will go to 253 leading researchers across Europe. Senior Group Leader, Dr Florian Markowetz, has been awarded a grant for his project ‘Targeting the roots of chromosomal instability in cancer (CliniCIN)’.
“Genomic chaos caused by chromosomal instability is a hallmark of most lethal cancers,” says Dr Markowetz. “Highly unstable tumours have few biomarkers to guide treatment decisions and patient survival has not improved for decades.
“I propose a novel single cell DNA sequencing approach to identify ongoing mutational processes from unique events in individual cells and use them to choose the best drug for each patient.
“It is a great privilege to be part of this amazing network of European researchers.”
ERC Advanced Grants are designed to support excellent scientists and scholars in any field at the career stage when they are already established research leaders, with a recognised track record of research achievements.
The 2021 Advanced Grants competition will see funding worth €624 million going to 253 leading researchers across Europe. This year, the UK has received grants for 45 projects, Germany 61, the Netherlands 27 and France 26. The overall ERC budget from 2021 to 2027 is more than €16 billion, as part of the Horizon Europe programme.
Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, said: “The ERC Advanced Grants support ground-breaking researchers throughout Europe. It gives our talents the possibility to realise their creative ideas. Their pioneering work contribute to solve the most pressing social, economic and environmental challenges.”
President of the ERC Prof. Maria Leptin commented: “Congratulations to the new grant winners in the latest round of ERC Advanced Grants! By following their scientific curiosity, these senior researchers are pushing the frontiers of our knowledge in a wide range of fields. It’s essential to fund this type of cutting-edge research to keep Europe at the scientific forefront.”
Related News
See all news-
World first trial to revolutionise treatment of brain cancer
23rd October 2024
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more -
Institute receives unprecedented £173M commitment from CRUK
15th October 2024
Cancer Research UK has announced a £173 million investment in the Cambridge Institute – the largest single grant ever awarded by the charity outside of London.
Find out more -
Madzia Crossley appointed as Junior Group Leader
1st October 2024
Dr Magdalena (Madzia) Crossley will be joining the Cancer Research UK Cambridge Institute as a Junior Group Leader starting in early 2025.
Find out more